Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis

Osteoporosis International

Volumn 16, Issue 12, 2005, Pages 1999-2004

  Lange, U ^a   Teichmann, J ^b   Strunk, J ^a   Muller Ladner U ^a   Schmidt, K L ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Medical Clinic C   (Germany)

Author keywords

Ankylosing spondylitis; Bone metabolism; Inflammation; Vitamin D metabolism

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CHOLECALCIFEROL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; SPONDYLITIS, ANKYLOSING; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN D DEFICIENCY;

EID: 29044450804     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-1990-5     Document Type: Article

References (37)

1. Will R, Palmer R, Bhalla AK, Ring F, Colin A (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483-1485
2. Bhalla AK, Shenstone B (1992) Bone densitometry measurements in early inflammatory disease. Baillières Clin Rheumatol 2(6):405-414
3. Gratacós J, Collado A, Pons F, Osaba M, Sanmarti R, Roqué M et al (1999) Significant loss of bone mass in patients with early active ankylosing spondylitis. Arthritis Rheum 42:2319-2324
4. Manolagas SCV (1995) Role of cytokines in bone resorption. Bone 16 [Suppl 1]:63-67
5. Manolagas SCV (1995) Bone marrow, clastic and blastic cell system: Quo vadis? Calcif Tissue Int 56 [Suppl 1]:2-53
6. Pacifici R (1995)Cytokines and osteoclast activity. Calcif Tissue Int 56 [Suppl 1]:27-28
7. Hahn G, Stuhlmueller B, Hain N, Kalden JR, Pfizemaier K, Burmester GR (1993) Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest 91:862-870
8. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P (1991) Interleukin-1β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10:15-21
9. Lange U, Jung O, Teichmann J, Neeck G (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031-1035
10. Moll LMH, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32:354
11. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218-1227
12. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisfrod P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
13. Payne RB, Carrver ME, Morgan DB (1979) Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32:56-60
14. Melton LJ 3rd, Lane AW, Cooper C, Eastell R, O'Fallon WM, Riggs BL (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3:113-119
15. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J (2005) Bone loss is more frequently detected in ankylosing spondylitis patients with syndesmophytes. J Rheumatol 32(7):1290-1298
16. Lange U, Kluge A, Teichmann J, Stracke H, Rau WS, Schmidt KL (2001) Bone density measurement by dual X-ray absorptiometry (DXA) and single energy-quantitative computed tomography (SE-QCT) in ankylosing spondylitis - critical comments. Akt Rheumatol 26:1-6
17. Lange U, Kluge A., Strunk J, Teichmann J, Bachmann G (2004) Ankylosing spondylitis and bone mineral density - What is the ideal tool for measurement? Rheumatol Int (epub ahead of print; (11)5:S0172-S172)
18. Ott V (1972) Klinik und Therapie der ankylosierenden Spondylitis (Morbus Strümpell-Marie-Bechterew) In: Brügel H (ed) Fortschritte auf dem Gebiet der rheumatischen Erkrankungen und der degenerativen Gelenkerkrankungen. Schattauer, Stuttgart, pp 92-104
19. Amento EP (1987) Vitamin D and the immune system. Steroids 49:55-72
20. Overbergh L, Decallonne B, Valckx D et al (1998) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120:139-146
21. Obermayer-Pietsch BM, Lange U, Tauber G, Frühauf G, Fahrleitner A, Dobnig H, Hermann J, Aglas F, Teichmann J, Neeck G, Leb G (2003) Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis. Osteoporos Int 14:995-1000
22. Quinn JM, Itoh K, Udagawa N (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect interactions. J Bone Miner Res 16:1787-1794
23. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507-511
24. Baeten D, Kruithof E, Van den Bosch F et al (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 44:186-195
25. Fernandez-Martin JL, Kurian S, Farmer P et al (1998) Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid -X receptors. Mol Cell Endocrinol 25:65-72
26. Kuno H, Kurian SM, Hendy GN et al (1994) Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Endocrinology 134:2524-2531
27. Schacht E (2000) Osteoporosis in rheumatoid arthritis: significance of alfacalcidol in prevention and therapy. Z Rheumatol 59:10-20
28. Shany S, Levy Y, Lahav-Cohen M (2001) The effects of 1alpha,24(S)- dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. Steroids 66:319-325
29. Fuss M, Pepersack T, Gillet C, Karmali R, Corvilain J (1992) Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol 11:28-36
30. Wemeau JL (1995) Calciotropic hormones and ageing. Horm Res 43:76-79
31. Bouillon R, Okmamura WH, Norman AW (1995) Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257
32. Toussirot E, Ricard-Blum S, Dumoulin G, Cedoz JP, Wendung D (1999) Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology 38:21-27
33. Compston JE, Vedi S, Croucher PI, Garrahan NJ, O Sullivan MM (1994) Bone turnover in non-steroid-treated rheumatoid arthritis. Ann Rheum Dis 53:1263-1266
34. Ekenstam E (1991) Influence of inflammation and corticosteroid treatment on indices of bone turnover and parathyroid function. Scand J Rheumatol 20:200
35. Langman CB, Ford, KK, Pachman LM, Glorieux F (1990) Vitamin D metabolism in rats with adjuvant-induced arthritis. J Bone Miner Res 5:905-913
36. Uzawa T, Hori M, Ejiri S, Ozawa H (1995) Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone. Bone 16:477-484
37. Teichmann J, Lange U, Stracke H, Doppl W, Klör HU, Federlin K (1997) Rapid trabecular bone loss in female patients with ileitis Crohn and additional sacroiliac joint inflammation. Rheumatol Int 17:45-48